Announced Tue, 21 Jul · 12:09 IST
Board approves Q1 FY27 results with mixed performance
Revenue DeclinePat NegativeRevenue Growth 20pctPat Growth 25pctEbitda Margin CompressionExceptional ItemResults View source PDF
GRANULES · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-3.2%1-day move
₹878.65
prior close
₹900.00
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-1.1-0.8-1.3-1.9-3.2-3.2-5.0-4.1——————
Up moveDown movePending
AI summary
Granules India board approved Q1 FY27 unaudited results on July 21, 2026. Standalone revenue fell 8.5 percent YoY to Rs 801.9 crore and PAT declined 27.5 percent to Rs 71.7 crore. Consolidated revenue rose 22 percent to Rs 1,476.8 crore and PAT jumped about 60 percent to Rs 180 crore, aided by subsidiaries including Senn Chemicals. Standalone EPS stood at Rs 2.90 versus Rs 4.04. Limited review by S.R. Batliboi was clean.
Likely market impact
Consolidated growth from acquisitions offsets standalone weakness. Ongoing USFDA warning letter on Gagillapur facility and warrant conversion remain key watch points.